Medicine & Life Sciences
Ovarian Neoplasms
100%
Heterografts
53%
Neoplasms
40%
Platinum
28%
Breast Neoplasms
27%
Endometrial Neoplasms
26%
Carcinoma
23%
Poly(ADP-ribose) Polymerase Inhibitors
21%
Drug Therapy
19%
Paclitaxel
18%
Carcinogenesis
16%
Estrogen Receptors
15%
Neoplasm Metastasis
15%
Growth
15%
Estrogens
15%
Carcinosarcoma
14%
Homologous Recombination
14%
Ovarian Epithelial Carcinoma
13%
Prostatic Neoplasms
13%
Therapeutics
12%
Human Mammary Glands
12%
Carboplatin
12%
Mutation
12%
DNA Damage
11%
Letrozole
10%
niraparib
10%
Somatomedins
9%
Survival
9%
DNA
8%
RNA Sequence Analysis
8%
olaparib
8%
Inbred ACI Rats
7%
dalotuzumab
7%
Genes
7%
Neuroblastoma
7%
Recurrence
7%
Gene Fusion
7%
Machine Learning
6%
Carcinoma, Intraductal, Noninfiltrating
6%
Methylation
6%
LY-2157299
6%
Non-gestational Choriocarcinoma
6%
ridaforolimus
6%
Nicotinamide N-Methyltransferase
6%
Clinical Trials
6%
ribociclib
6%
Phosphorylation
6%
Adenosine Diphosphate Ribose
6%
Epigenomics
6%